动态CT与钆塞酸二钠增强MRI中央瘢痕样结构差异在鉴别FNH与HCA中的价值
该回顾性研究纳入113例病理确诊的FNH(80例)或HCA(37例)患者,评估动脉期CT和肝胆期MRI上中央瘢痕样结构的可见性或大小差异。多因素分析显示,动脉期CT与肝胆期MRI间中央瘢痕样结构差异及肝胆期MRI非瘢痕部分无低信号提示FNH,AUC为0.96(95%CI 0.93-0.99)。
要点
- 动脉期CT与肝胆期MRI中央瘢痕样结构可见性/大小差异提示FNH(FNH 73.8% vs HCA 16.2%)。
- 肝胆期MRI非瘢痕部分无低信号提示FNH,联合瘢痕差异AUC达0.96。
- 观察者间一致性中度至优秀(ICC≥0.74,kappa≥0.65)。
关键影像表现/征象
- 中央瘢痕样结构存在与否在FNH与HCA间差异显著(P<0.001)。
- 动脉期CT与肝胆期MRI间中央瘢痕样结构差异在FNH中占73.8%,HCA中占16.2%(P<0.001)。
- 动脉期与肝胆期MRI间中央瘢痕样结构差异在FNH中占70.0%,HCA中占16.2%(P<0.001)。
- 非瘢痕肿瘤部分特征在FNH与HCA间差异显著(P≤0.011)。
诊断标准与关键数值
- 多因素分析中,动脉期CT与肝胆期MRI间中央瘢痕样结构差异提示FNH(P=0.036)。
- 肝胆期MRI非瘢痕部分无低信号提示FNH(P<0.001)。
- 联合上述特征的ROC曲线下面积为0.96(95%CI 0.93-0.99)。
临床应用与阅片要点
- 阅片时注意比较动脉期CT与肝胆期MRI上中央瘢痕样结构的可见性和大小差异。
- 关注肝胆期MRI非瘢痕肿瘤部分是否呈低信号,无低信号提示FNH。
局限性
- 回顾性研究设计。
- 样本来自单中心,FNH与HCA比例不平衡(80 vs 37)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify the value of discrepancies in the central scar (CS)-like structure between dynamic CT and gadoxetate disodium-enhanced MRI for differentiating FNH from HCA.
METHODS: This retrospective study included 113 patients with pathologically-diagnosed FNH (n = 80) or HCA (n = 37). CS-like structures were evaluated on arterial phase (AP) CT and hepatobiliary phase (HBP) MRI. Presence of the CS-like structure, its discrepancy in visibility or size between AP CT and HBP MRI and between AP and HBP MRI, and features of non-scarred tumor portion were evaluated by two radiologists. Inter-observer agreement was evaluated by intraclass correlation coefficients (ICCs) and weighted kappa. Univariable and multivariable logistic regression and ROC analysis were performed to explore features differentiating FNH from HCA.
RESULTS: Inter-observer agreement was moderate-to-excellent (ICCs≥0.74, kappa≥0.65). On univariable analysis, presence of CS-like structures (P < 0.001), discrepancy of the CS-like structures between AP CT and HBP MRI (73.8 % in FNH; 16.2 % in HCA, P < 0.001) and between AP and HBP MRI (70.0 % in FNH; 16.2 % in HCA, P < 0.001), and the features of non-scarred tumor portion (P ≤ 0.011) were significantly different between FNH and HCA. On multivariable analysis, the discrepancy of CS-like structures between AP CT and HBP MRI, and the absence of low SI of the non-scarred tumor portion on HBP MRI, were suggestive of FNH (P = 0.036 and P < 0.001, respectively; area under the ROC curve, 0.96 [95 % CI, 0.93-0.99]).
CONCLUSION: Evaluation of discrepancy in the visibility or size of CS-like structures between dynamic CT and gadoxetate disodium-enhanced MRI may facilitate the differentiation of FNH from HCA.
引用
- Park HJ, Byun JH, Kang JH, et al. Value of discrepancy of the central scar-like structure between dynamic CT and gadoxetate disodium-enhanced MRI in differentiation of focal nodular hyperplasia and hepatocellular adenoma. Eur J Radiol. 2021. PMID: 33930719. doi:10.1016/j.ejrad.2021.109730
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。